| Home > Zentren > Zentrum für Innere Medizin > III. Medizinische Klinik und Poliklinik > Publikationen

Publikationen

Assemat E, Vinot S, Gofflot F, Linsel-Nitschke P, Illien F, Chatelet F, Verroust P, Louvet-Vallee S, Rinninger F, Kozyraki R: Expression and role of cubilin in the internalization of nutrients during the peri-implantation development of the rodent embryo. Biol Reprod. 72: 1079-1086, 2005

Brundert M, Ewert A, Heeren J, Behrendt B, Ramakrishnan R, Greten H, Merkel M, Rinninger F: Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice. Arterioscler Thromb Vasc Biol 25: 143-148, 2005

Dierkes J, Hoffmann K, Klipstein-Grobusch K, Weikert C, Boeing H, Zyriax BC, Windler E, Kratzsch J: Low plasma pyridoxal-5'phosphate and cardiovascular disease risk in women: results from the Coronary Risk Factors for Atherosclerosis in Women Study. Am J Clin Nutr 81: 725-727; author reply 727-728, 2005

Evans D, Seedorf U, Beil FU: Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia. Clin Genet 68: 369-372, 2005

Grewal T, Evans R, Rentero C, Tebar F, Cubells L, de Diego I, Kirchhoff MF, Hughes WE, HeerenJ , Rye KA, Rinninger F, Daly RJ, Pol A Enrich C: Annexin A6 stimulates the membrane recruitment of p120GAP to modulate Ras and Raf-1 activity. Oncogene 24: 5809-5820, 2005

Hansen-Algenstaedt N, Joscheck C, Schaefer C, Lamszus K, Wolfram L, Biermann T, Algenstaedt P, Brockmann MA, Heintz C, Fiedler W, Ruther W: Long-term observation reveals time-course-dependent characteristics of tumour vascularisation. Eur J Cancer 41: 1073-1085, 2005

Hansen-Algenstaedt N, Schaefer C, Wolfram L, Joscheck C, Schroeder M, Algenstaedt P, Ruther W: Femur window - a new approach to microcirculation of living bone in situ. J Orthop Res 23: 1073-1082, 2005

Harendza S, Hübner CA, Gläser C, Burdelski M, Thaiss F, Hansmann I, Gal A, Stahl RAK: Renal failure and hypertension in Alagille syndrome with a novel JAG1 mutation. J Nephrol. 18: 312-317, 2005

Krebs C, Adriouch S, Braasch F, Koestner W, Leiter EH, Seman M, Lund FE, Oppenheimer N, Haag F, Koch-Nolte F: CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins. J Immunol 174 (6):3298-3305, 2005

Merkel M, Heeren J: Give me A5 for lipoprotein hydrolysis! J Clin Invest 115: 2694-2696, 2005

Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, Laatsch A, Heeren J: Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 280: 21553-21560, 2005

Panzer U, Schneider A, Steinmetz OM, Barth P, Reinking RR, Becker JU, Harendza S, Zahner G, Fischereder M, Krämer BH, Schlöndorff D, Ostendorf T, Floege J, Helmchen

U, Stahl RAK: The chemokine receptor 5 _32 mutation is associated with increased renal survival in patients with IgA nephropathy. Kidney Int 67: 75-81, 2005

Pischon T, Bamberger CM, Kratzsch J, Zyriax BC, Algenstaedt P, Boeing H, Windler E: Association of plasma resistin levels with coronary heart disease in women. Obes Res 13: 1764-1771, 2005

Ragozin S, Niemeier A, Laatsch A, Loeffler B, Merkel M, Beisiegel U, Heeren J: Knockdown of hepatic ABCA-1 by RNA interference decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice. Arteriosler Thromb Vasc Biol 25: 1433-1438, 2005

Steinmetz OM, Panzer U, Kneissler U, Harendza S, Lipp M, Helmchen U, Stahl RAK: BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int 67: 1616-1621, 2005

van den Bussche H, Anders S, Ehrhardt M., Göttsche T, Hüneke B, Kohlschütter A, Kothe R, Kuhnigk O, Neuber K, Rijntjes M, Quellmann C, Harendza S: Lohnt sich eine Reform der klinischen Ausbildung? Ð Die Qualität des Hamburger Curriculums unter der alten und der neuen Approbationsordnung im Vergleich. Z Ärztl Fortbild Qual Gesundhwes 99: 419-423, 2005

Weikert C, Hoffmann K, Dierckes J, Zyriax BC, Klipstein-Grobusch K, Schulze MB, Jung R, Windler E, Boeing H: A homocysteine metabolism-related dietary pattern and the risk coronary heart disease in two independent German study populations. J Nutr 135: 1981-1988, 2005

Windler E: What is the consequence of an abnormal lipid profile in patients with type 2 diabetes or the metabolic syndrome? Atheroscler Suppl 6: 11-14, 2005

Wolf G, Wenzel U, Jablonski K, Brundert M, Rinninger F: Angiotensin II down-regulates the SR-BI HDL receptor in proximal tubular cells. Nephrol Dial Transplant 20: 1222Ð1227, 2005

Wolf G, Schanze A, Stahl RAK, SJ, Shankland, Amann K: p27Kip1 knockout mice are protected from diabetic nephropathy: Evidence for p27Kip1 haptotype insufficieny1. Kidney Intern 68:1583-1589, 2005

Yeh TY, Sbodio JI, Nguyen MT, Meyer TN, Lee RM, Chi NW: Tankyrase-1 overexpression reduces genotoxin-induced cell death by inhibiting PARP1. Mol Cell Biochem 276 (1-2):183-192, 2005

Zyriax BC, Boeing H, Windler E: Nutrition is a powerful independed risk factor for coronary heart disease in women Ð The CORA study: a population-based case-control study. Eur J Clin Nutr 59: 1201-1207, 2005

Übersichtsarbeiten 2005

Kasperk HC, Kruse HP: CME: Morbus Paget Ð Diagnostik und Therapie. Springer, http://www.bsmo.de Berlin, 2005

Kruse HP: Aktuelle Osteoporosetherapie: Potential für Optimierungen? OrthopSdie im Umbruch 1: 32-33, 2005

Wenzel U, Wolf G: Blutdruckunabhängige Wirkungen von Antihypertensiva. Der Internist 46: 548-556, 2005

Buchbeiträge 2005

Kruse HP: Metabolische Osteopathien. In: H Greten, Hrsg: Innere Medizin, 12. Auflg, 533-541, Thieme, Stuttgart 2005

Kruse HP: Knochen. In: H Greten, Hrsg: Innere Medizin, 12. Auflg, 1136-1143, Thieme, Stuttgart 2005

Wenzel U, Helmchen U: Effects of hypertension on renal vasculature and structure, in Oxford Textbook of Clinical Nephrology. Edited by Davidson AM, Cameron JS, Grünfeld JP, Ponticelli C, Ritz E. Winearls CG, van Ypersele C, Oxford Medical Publications, Oxford, 1329-1342, 2005

Originalarbeiten 2004

Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E: Health-economic comparison of three recommended drugs for the treatment of osteoporosis. Int J Clin Pharm Res 24: 1-10; 2004

Bush KT, Sakurai H, Steer DL, Leonard MO, Sampogna RV, Meyer TN, Schwesinger C, Qiao J, Nigam SK: TGF-ß superfamily members modulate growth, branching, shaping, and pattering of the ureteric bud. Dev Biol 266: 285-298; 2004

Harendza S, Ahrens M, Schneider A, Pfalzer B, Erbersdobler A, Helmchen U, Feller AC, Stahl RAK: Dysfunktion einer Transplantatniere mit bedrohlichem Befund. Der Internist 45: 592-596; 2004

Harendza S, Anders S, Ehrhardt M, Göttsche T, Harren W, Hüneke B, Kellner M, Kohlschütter A, Kothe R, Neuber K, Quellmann C, Rijntjes M, van den Bussche H, Stahl RAK: KliniCuM: Das neue klinische Curriculum am UKE. Hamburger Ärzteblatt 6: 298-299; 2004

Meyer TN, Schwesinger C, Bush KT, Stuart RO, Steer D, Nigam SK: Spatioemporal regulation of morphogenetic molecules during in vitro branching of the isolated ureteric bud. Dev Biol 275: 44-67; 2004

Meyer TN, George SK, Bush KT, Abdeen O, Nigam SK: Tunicamycin preserves cellular architecture and cell junctions and prevents E-cadherin degradation in ATP-depleted cells. Biochem Biophys Res Commun 322: 223-231; 2004

Panzer U, Reinking RR, Steinmetz OM, Zahner G, Südbeck U, Schneider A, Pfalzer B, Thaiss F, Mack M, Conrad S, Huland H, Helmchen U, Stahl RAK: CXCR3 and CCR5 positive T cell recruitment in acute human renal allograft rejection. Transplantation 78: 1341-1350; 2004

Panzer U, Uguccioni M: Prostaglandin E2 modulates the functional responsiveness of human monocytes to chemokines. Eur J Immunol 34: 3682-3689; 2004

Schneider A, Zhang Y, Shu S, Lu WJ, Fan X, Redha R, Davis L, Breyer RM, Harris R, Breyer MD, Guan Y: Membrane-associated PGE Synthese-1 (mPGES-1) is co-expressed with both COX-1 and COX-2. Kidney Int 65: 1205-1213; 2004

Schneider A, Guan Y, Zhang Y, Magnuson MA, Pettepher C, Loftin CD, Langenbach R, Breyer RM, Breyer MD: Generation of a conditional allele of the mouse prostaglandin EP4 receptor. Genesis 40: 7-14; 2004

Seibold S, Schürle D, Heinloth A, Wolf G, Wagner M, Galle J: Oxidized LDL induces proliferation and hypertrophy in human endothelial cells via regulation of p27Kip1 expression-role of RhoA and oxidative stress. J Am Soc Nephrol 15: 3026-3034; 2004

Steer DL, Shah MM, Bush KT, Stuart RO, Sampogna RV, Meyer TN, Schwesinger C, Bai X, Esko JD, Nigam SK: Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney. Dev Biol 272: 310-327; 2004

Steinmetz OM, Panzer U, Harendza S, Mertens PR, Ostendorf T, Floegge J, Helmchen U, Stahl RAK: No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy. Nephrol Dial Transpl 19: 596-601; 2004

Tomita N, Kim JYS, Gibbons GH, Zhang L, Kaneda Y, Stahl RAK, Ogborn M, Venderville B, Morischita R, Baran D, Dzau VJ: Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis. Int J of Molecular Med 13: 629-636; 2004

Wolf G, Schroeder R, Stahl RAK: Angiotensin II induces hypoxia-inducible factor-1_ in PC 12 cells through a posttranscriptional mechanisms: Role of AT2-receptors. Am J Nephrol 24: 415-421; 2004

Wolf G, Meyer TN, Baumann-Schölzke J, Stahl RAK: An expensive case of renal failure. Nephrol Dial Transplant 19: 2921-2922; 2004

Wolf G: Georg Büchner´s "Woyzeck -a tragic example of human experimentation without informed consent. The Pharos 67: 23-28; 2004

Wolf G, Hüneke B, Ebel S, Helmchen U, Stahl RAK: Der besondere Fall: Schwangere mit generalisierten Ödemen. Hamburger Ärzteblatt 59: 73-74; 2004

Wolf G, Schroeder R, Ziyadeh FN, Stahl RAK: Albumin upregulates the type II transforming growth factor beta receptor in cultured proximal tubular cells. Kidney Int 66: 1849-1858; 2004

Wolf G, Schneider C, Petri S, Helmchen U, Stahl RAK: A 63-year old man with acute abdominal pain and laboratory signs of rapid progressive renal disease. Nephrol Dial Transplant 19: 742-744; 2004

Panzer U, Kluge S, Kreymann G, Wolf G: Combination of intermittent hemodialysis and high volume continous hemofiltration for the treatment of severe metformin induced lactic acidosis (letter). Nehrol Dial Transplant 19: 2157-2158; 2004

Übersichtsarbeiten 2004

Kruse HP: Osteoporose; Prinzipielle Unterschiede antiresorptiver und osteoanaboler Behandlungsoptionen. Osteoporose & Rheuma aktuell 4: 24-27; 2004

Schneider A, Stahl RAK: Die Nierenbeteiligung beim systemischen Lupus erythematodes. Nieren- und Hochdruckkrankheiten 33: 57-69; 2004

Wenzel UO, Wolf G: Schlusswort Leserbriefe Hemmung des Fortschreitens von chronischen Nierenerkrankungen durch Blockierung des Renin-Angiotensin-Systems. Deutsches Ärzteblatt 101: A52-A54; 2004

Wolf G: Mechanismen der Progression. Mitteil Arbeitsg Klin Nephrol 33: 17-27; 2004

Wolf G: Pathogenese des systemischen Lupus erythematosus. Nieren- und Hochdruckkrankheiten 33: 50-56; 2004

Wolf G, Wenzel U: Angiotensin II and cell cycle regulation. Hypertension 43: 693-698; 2004

Wolf G: Not known from ADAM (TS-13)-novel insights into the pathophysiology of thrombotic microangiopathies. Nephrol Dial Transplant 19: 1687-1693; 2004

Wolf G: Neue Aspekte zur Pathophysiologie von thrombotischen Mikroangiopathien. Spektrum der Nephrologie 17: 9 - 16; 2004

Wolf G: PPAR_ Agonisten und Nephroprotektion. Dialyse aktuell. 8: 50-54; 2004

Wolf G: Pathophysiologie und natürlicher Verlauf der diabetischen Nephropathie. Med. Report 27: 7, 2004

Wolf G: Molekulare Mechanismen der diabetischen Nephropathie. Diabetes News 6: 8; 2004

Wolf G: New insights into the pathophysiology of diabetic nephropathy: from hemodynamics to molecular pathology. European J Clin Invest 34: 785-796; 2004

Originalarbeiten 2003

Harendza S, Lovett DH, Panzer U, Lukacs Z, Kühnl P, Stahl RAK: Linked common polymorphisms in the gelatinase A promoter are associated with dimmished transcriptional response to estrogen and genetic fitness. J Biol Chem 278: 20490-20499; 2003

Henningsen C, Zahner G, Thaiss F: High glucose induces typ 1 hexokinase gene expression in isolated glomeruli of diabetic rats and in mesangial cells. Nephron Physiol 93: 67-75, 2003

Janneck M, Stahl RAK: Vaskulitiden - Frühe Diagnose verbessert die Prognose. Hamburger Ärzteblatt 4: 177-179; 2003

Janssen U, Eitner F, Kunter U, Ostendorf T, Wolf G, Chaponnier C, Gabbiani G, Kerjaschki D, Floege J: Extracellular actin impairs glomerular capillary repair in experimental mesangioproliferative nephritis. Nephron 93: e158-e167, 2003

Kneißler U, Harendza S, Helmchen U: Support film in transmission electron microscopy: experiences with polyvinylbutyral Pioloform BM 18. J Electron Microsc 52: 355-357; 2003

Meyer TN, Hunt J, Schwesinger C, Denker BM: Ga 12 regulates epithelial cell junctions through Src tyrosine kinases. Am J Physiol Cell Physiol 285: C1281-1293, 2003

Peti-Peterdi J, Komlosi P, Fuson AL, Guan Y, Schneider A, Qi Z, Redha R, Rosivall L, Breyer MD, Bell PD: Luminal NaCl delivery regulates basolateral prostaglandin E2 release from macula densa cells. J Clin Invest 112: 76-82; 2003

Pientka L, Baum E, Götte S, Kruse HP, Lüttje D, Ringe JD, Pfeilschifter J: Osteoporose des älteren Menschen. Evidenz-basierte Konsensus-Leitlinie zur Osteoporose im Auftrag des Dachverbandes Deutschsprachiger Wissenschaftlicher Gesellschaften für Osteologie (DVO), April 2003 www.bergmannsheil.de/leitlinien-dvo

Pientka L, Baum E, Götte S, Kruse HP, Lüttje D, Pfeilschifter J, Ringe JD: DVO-Leitlinie Osteoporose des älteren Menschen. Osteologie 12: 93-117; 2003

Pocock J, Gómez-Guerrero C, Harendza S, Ayoub M, Hernandez-Varga P, Zahner G, Stahl RAK, Thaiss F: Differential activation of NF-kB, AP-1 and C/EBP in endotoxin-tolerant rats: mechanisms for in vivo regulation of glomerular RANTES/CCL5 expression. J Immunol 170: 6280-6291; 2003

Reinhardt K, Schrameyer-Wernecke A, Beil FU, Kruse HP: Auswirkungen des H.E.L.P.-Verfahrens (LDL-Apherese) auf den Lipoprotein- und Knochenstoffwechsel. Osteologie 12: 31-39; 2003

Schneider A, Zhang Y, Guan Y, Davis LS, Breyer MD: Differential, inducible gene targeting in renal epithelia, vascular endothelium, and visceral organs of Mx1Cre mice. Am J Physiol Renal Physiol 284: F411-F417; 2003

Wenzel U, Wolf G, Jacob I, Schwegler C, Quasqas A, Aman K, Helmchen U, Stahl RAK:Beneficial and adverse renal and vascular effects of the vasopeptidase inhibitor omapatrilat in renovascular hypertensive rats. Nephrol Dial Transplant 18: 2005-2013; 2003

Wolf G, Stahl RAK: CD2-associated protein and glomerular disease. Lancet 362: 1746-1748; 2003

Wolf G, Schroeder R, Reinking R. Zahner G, Stahl RAK, Shankland SJ: Erk 1,2 phosphorylates p27Kip1: functional evidence for a role in high glucose-induced hypertrophy of mesangial cells. Diabetologia 46: 1090-1099, 2003

Wolf G, Jablonski K, Schroeder R, Reinking R, Shankland SJ, Stahl RAK: Angiotensin II-induced hypertrophy of proximal tubular cells requires p27Kip1. Kidney Int 64: 71-81, 2003

Zhang Y, Schneider A, Rao R, Lu WJ, Fan X, Davis L, Breyer RM, Breyer MD, Guan Y: Genomic structure and genitourinary expression of mouse cytosolic prostaglandin E2 synthase gene. Biochimica et Biophysica Acta 1634: 15-23; 2003

Übersichtsarbeiten 2003

Kruse HP, Frieling I: Medikamentöse Osteoporosetherapie: Nicht nur effektiv, sondern auch wirtschaftlich ? Der niedergelassene Arzt 2: 34-40; 2003

Scheidat S, Stahl RAK: Membranöse Glomerulonephritis. Internist 44:1120-1130; 2003

Wenzel UO, Böger R: Die antihypertensive Therapie der arteriellen Hypertonie. Welches Antihypertensivum ist das beste? Mehr Rationalität in der Arzneimitteltherapie nach der ALLHAT Studie? Med Welt 54:285-292, 2003

Wenzel U, Dominiak P, Neumayer HH, Wolf G: Hemmung der Progression von chronischen Nierenerkrankungen. Therapie durch Blockierung des Renin-Angiotensin-Systems. Deutsches Ärzteblatt 100: A2072-A2079; 2003

Wenzel U, Wolf G: Nephroprotektion durch Hemmung des Renin-Angiotensin-Systems: Genügt ein Medikament ? Mitteil Arbeitsg Kein Nephrol 32, 59-73 (2003)

Wolf G: Angiotensin II als proinflammatorischer Faktor bei Nierenerkrankungen. Dialyse aktuell 7: 6 -9; 2003

Wolf G; Butzmann U, Wenzel U: The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron 93: 3-13; 2003

Wolf G, Shankland SJ: p27 Kip1-the "Rosebud" of diabetic nephropathy ? (Editorial). J Am Soc Nephrol 14: 819-822, 2003

Wolf G, Ritz E: Diabetic nephropathy in type 2 diabetes: prevention and patient management. J Am Soc Nephrol 14: 1396-1405; 2003

Wolf G: Pathophysiologische Effekte von Leptin an der Niere. Nephro-News 4: 1-5; 2003

Wolf G: Adipositas und Nierenerkrankungen. Spektrum der Nephrologie 16: 154-21, 2003

Wolf G: Rasch progrediente Glomerulonephritis - ein nephrologischer Notfall. Deutsches Ärzteblatt 100: A2123-A2125; 2003

Wolf G: Growth factors and the development of diabetic nephropathy. Current Diabetes Reports 3: 485-490; 2003

Wolf G: After all those fat years - Renal consequences of obesity. Nephrol Dial Transplant 18: 2471-2474; 2003

Wolf G: Aktivierung des Renin-Angiotensin Systems durch Proteinurie. Med Report 27: 11; 2003

Wolf G: Recent insights into the renin-angiotensin aldosterone system and progression of renal disease. Invited contribution, 3rd Congress of Nephrology in Internet, 10. - 25.11.2003

Ziyadeh FN, Wolf G: Why should an angiogenic factor modulate tubular structure in diabetic nephropathy ? Some answers, more questions (Editorial). Kidney Int 64: 758-759; 2003

Originalarbeiten 2002

Ameis D, Knolinski T, Guthoff A, Wenzel U, Greten H: 48-jähriger Patient mit rechtsseitigen Flankenschmerz und neu aufgetretener Hypertonie. Der Internist 43:1129-1132, 2002

Gerth JH, Kriegsmann J, Trinh TT, Stahl RAK, Wendt T, Sommer M, Stein G, Wolf G: Induction of p27Kip1 after unilateral ureteral obstruction is independent of angiotensin II. Kidney Int 61:68-79, 2002

Guan Y, Stillmann B, Zhang Y, Schneider A, Saito O, Davis LS, Redha R, Breyer RM, Breyer MD: Cloning and expression of the rabbit prostaglandin EP2 receptor. BMC Pharmacol 2:14; 2002

Haberstroh U, Pocock P, Gómez-Guerrero C, Helmchen U, Hamann A, Gutierrez-Ramos JC, Stahl RAK, Thaiss F: Infiltrating inflammatory cells contribute to renal RANTES gene expression. Kidney Int 62:1264-1276, 2002

Kruse HP. Evidenzbasierte Medizin und Ökonomie der medikamentösen Osteoporosetherapie. Osteologie 11: 88-95; 2002

Meyer TN, Schwesinger C, Denker BM: Zonula occludens-1 is a scaffolding protein for signaling molecules. Galpha (12) directly binds to the Src homology 3 domain and regulates paracellular permeability in epithelial cells. J Biol Chem 277:24855-24858, 2002

Monkawa T, Hiromura K, Wolf G, Shankland SJ: Transforming growth factor-beta requires the cyclin-dependent kinase-inhibitors p21 and p27 to induce mesangial cell hypertrophy. J Am Soc Nephrol 13:1172-1178, 2002

Panzer U, Schneider A, Guan Y, Reinking R, Zahner G, Harendza S, Wolf G, Thaiss F, Stahl RAK: Effect of different PPARgamma-agonists on MCP-1 expression and monocyte infiltration in experimental glomerulonephritis. Kidney Int 62:455-464, 2002

Steer DL, Bush KT, Meyer TN, Schwesinger C, Nigam SK: A strategy for in vitro propagation of rat nephrons. Kidney Int 62:1958-1965, 2002

Wenzel U, Thaiss F, Helmchen U, Stahl RA, Wolf G: Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis. Kidney Int 61:1020-1029, 2002

Wenzel U, Röben T, Schwietzer G, Stahl RAK: Die Therapie der arteriellen Hypertonie. Hamburger Ärzteblatt 4/02:174-173, 2002

Wenzel U, Wolf G, Jacob I, Thaiss F, Helmchen U, Stahl RAK: Chronic anti Thy-1 nephritis is aggravated in the nonclipped but not in the clipped kidney of Goldblatt hypertensive rats. Kidney Int 61:2119-2131, 2002

Wolf G, Butzmann U, Wenzel U: The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiology 93:3-13, 2002

Wolf G, Stahl RAK: Remembrance of things past: tumoural calcifications in a hemodialysis patient. Nephrol Dial Transplant 17:304-307, 2002

Wolf G, Stahl RAK: A lady with increasing weakness of the legs and irregular heart beat who took her husband´s medication. Nephrol Dial Transplant 17:1698-1701, 2002

Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RAK, Thaiss F: Angiotensin II activates nuclear transcription factor kB through AT1 and AT2 receptors. Kidney Int 61:1986-1995, 2002

Wolf G, Panzer U, Harendza S, Wenzel U, Stahl RAK: No association between a genetic variant of the p22phox component of NAD(P)H oxidase and the incidence and progression of IgA nephropathy. Nephrol Dial Transplant 17:1509-1512, 2002

Wolf G: Buchrezension-Jehle/Deuber: Renale Osteopathie. Hamburger Ärzteblatt 56: 140-141, 2002

Wolf G, Harendza S, Schroeder R, Wenzel U, Zahner G, Freeman RS, Stahl RAK: AT2 receptor-mediated antiproliferation depends on down-regulation of SM-20. Lab Invest 82:1305-1317, 2002

Wolf G, Jocks T, Zahner G, Panzer U, Stahl RAK: Existence of a regulatory loop between MCP-1 and TGF-beta in glomerular immune injury: Evidence from studies in the isolated perfused kidney. Am J Physiol 283:F1075-F1084, 2002

Wolf G: Friedrich Theodor von Frerichs (1819-1885) and Bright´s disease. Am J Nephrol 22:596-602, 2002

Wolf G: Buchrezension-Keller: Praxis der Nephrologie. Hamburger Ärzteblatt 56:421,2002

Zahner G, Wolf G, Ayoub M, Reinking R, Panzer U, Shankland SJ, Stahl RAK: Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin dependent kinase inhibitors p21waf1/cip1 and p27Kip1. J Biol Chem 277:9763-9771, 2002

Übersichtsarbeiten 2002

Kruse HP, Hinkel U: Calcium und Vitamin D-physiologische Funktionen und die Bedeutung einer kombinierten Supplementierung. Dtsch Apoth Ztg 142: 88-95; 2002

Wolf G, Chen S, Han DC, Ziyadeh FN: Leptin and renal disease. Am J Kidney Dis 39: 1-11, 2002

Wolf G: Angiotensin II and tubular development. Nephrol Dial Transplant 17 (Suppl.9): 48-51, 2002

Wolf G: "The road not taken": role of angiotensin II type 2 receptor in pathophysiology. Nephrol Dial Transplant 17: 195-198, 2002

Wolf G, Hüneke B: Physiologische Veränderungen des mütterlichen Kreislaufsystems und der Nierenfunktion in der normalen Schwangerschaft. Nieren- und Hochdruckkrankheiten 31: 222-233, 2002

Wolf G: "Laßt wohlbeleibte Männer um mich sein": Leptin und Nierenerkrankungen. Nieren- und Hochdruckkrankheiten 31: 163-171, 2002

Wolf G: Angiotensin II als Wachstumsfaktor für proximale Tubuluszellen. Nieren- und Hochdruckkrankheiten 31: 320-323, 2002

Wolf G: Molecular mechanisms of diabetic mesangial cell hypertrophy: a proliferation of novel factors (Editorial). J Am Soc Nephrol 13: 2611-2613, 2002

Wolf G: Was ist Therapie der Wahl bei Typ 2 Diabetikern mit Mikroalbuminurie ? ACE-Hemmer oder AT1-Blocker ? Cardiovasc 5: 8-10, 2002

Originalarbeiten 2001

Harendza S, Pfalzer B, Arndt L, Ahrens M, Bode F, Stahl RAK: Der besondere Fall: Phantomschmerz mit Folgen. Hamburger Ärzteblatt 6-7:318-319; 2001

Kruse HP: Ökonomische Aspekte der Osteoporosetherapie. MMW Fortschr Med 143:33-36; 2001

Behnke B, Kemper MJ, Kruse HP, Müller-Wiefel DE: Bone mineral density in children with primary hyperoxaluria type I. Nephrol Dial Transplant 16:2236-2239; 2001

Panzer U, Thaiss F, Zahner G, Barth P, Reszka M, Reinking R, Wolf G, Helmchen U, Stahl RAK: Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney Int 59:1762-1769; 2001

Fischereder M, Luckow B, Hocher B, Wuthrich RP, Rothenpieler U, Schneeberger H, Panzer U, Stahl RAK, Hauser IA, Budde K, Neumayer H, Kramer BK, Land W, Schlöndorff D: CC chemokine receptor 5 and renal-transplant survival. Lancet 357:1758-1761; 2001

Guan Y, Zhang Y, Schneider A, Riendeau D, Mancini JA, Davis L, Komhoff M, Breyer RM, Breyer MD: Urogenital distribution of a mouse membrane-associated prostaglandin E2 synthase. Am J Physiol Renal Physiol 281:F1173-F1177; 2001

Guan Y, Zhang Y, Schneider A, Davis L, Breyer RM, Breyer MD: Peroxime proliferator-activated receptor g (PPARg) activity is associated with renal microvasculature. Am J Physiol Renal Physiol 281:F1031-F1046; 2001

Hannken T, Schroeder R, Stahl RAK, Wolf G: Atrial natriuretic peptide attenuates angiotensin II-induced hypertrophy of renal tubular cells. Am J Physiol 281:F81-F90; 2001

Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RAK, Warnholz A, Meinertz T, Griendling K, Harrison DG, Förstermann U, Münzel T: Mechanismus underlying endothelial dysfunction in diabetes mellitus. Circulation Res 88: E14-E22; 2001

Reblin T, Donarski N, Bräsen JH, Diplinger H, Thaiss F, Stahl RAK, Beisiegel U, Wolf G: Renal handling of human apolipoprotein (a) and its fragments in the rat. Am J Kidney Dis 38:619-630; 2001

Wenzel U, Röben T, Schwietzer G, Stahl RAK: Die Therapie der arteriellen Hypertonie. Eine Umfrage bei niedergelassenen Ärzten. Dtsch Med Wochenschr 126:1454-1459; 2001

Efsen E, Bonacchi A, Pastacaldi S, Valente AJ, Wenzel UO, Tosti-Guerra C, Pinzani M, Laffi G, Abboud HE, Gentilini P, Marra F: Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells. Hepatology 33:713-21; 2001

Wolf G, Krenz I, Hegewisch-Becker S, Hossfeld DK, Helmchen U, Stahl RAK: Necrotizing glomerulonephritis associated with Hodgkin´s disease (letter). Nephrol Dial Transpl 16:187-188; 2001

Kemper M, Wolf G, Müller-Wiefel D: Transmission of glomerular permeability factor from a mother to her child (letter). N Engl J Med 344:386-387; 2001

Wolf G, Porth J, Stahl RAK: Thrombosis associated with cytomegalovirus infection in patients with ANCA-positive vasculitis. Report of three cases. Am J Kidney Dis 38:E27-E32; 2001

Wolf G: Thomas Mann´s "The Transposed Heads": an accidental case of allogenic transplantation with unfavorable outcome. The Pharos 64:8-11; 2001

Wolf G: Paul Klee und Sklerodermie. Frauenheilkunde Aktuell 10:26-30; 2001

Han DC, Isono M, Chen S, Hong SW, Casaretto A, Wolf G, Ziyadeh FN: Leptin stimulates type I collagen production in db/db mesangial cells: mediation by increased glucose uptake and TGF-ß typ II receptor expression. Kidney Int 59:1315-1323; 2001

Wolf G, Hannken T, Schroeder R, Zahner G, Ziyadeh FN, Stahl RAK: Antioxidant treatment induces transcription and expression of transforming growth factor beta in cultured renal proximal tubular cells. FEBS letters 488:154-159; 2001

Wolf G, Schroeder R, Zahner G, Stahl RAK, Shankland SJ: High glucose-induced hypertrophy of mesangial cells requires p27Kip1, an inhibitor of cyclin-dependent kinases. Am J Pathol 158:1091-1100; 2001

Wolf G, Wenzel U, Hannken T, Stahl RAK: Angiotensin II induces p27Kip1 expression in renal tubules in vivo: role of reactive oxygen species. J Mol Med 79:383-389; 2001

Wolf G, Harendza S, Wenzel U, Stahl RAK: Identifizierung von SM-20 als wichtiges Zielgen der durch AT2-Rezeptoren vermittelten Proliferationshemmung. Nieren- und Hochdruckkrankheiten 30:196-197; 2001

Übersichtsarbeiten 2001

Kudlacek S, Leidig-Bruckner G, Scharla SH, Pfeilschifter J, Kruse HP, Keck E, Willvonseder R: Zur Prävention der Osteoporose. Dtsch Med Wschr 126:793-797; 2001

Wolf G, Wenzel U, Stahl RAK, Hüneke B: Hypertensive Erkrankungen in der Schwangerschaft. Med Klinik 96:78-86; 2001

Wolf G: Angiotensin II als pro-inflammatorisches Zytokin für die Niere. Nieren- und Hochdruckkrankheiten 30:359-366; 2001

Wolf G: Cell cycle regulation of renal hypertrophy. Invited contribution, 2st Congress of Nephrology in Internet, 5.-30.11.2001, www.uninet.edu/cin2001/

Wolf G: Proteinurie-Marker oder Motor von Nierenerkrankungen? Dialyse Aktuell 8:6-10; 2001

Wolf G: Molekulare Mechanismen der Mesangiumzellhypertrophie bei der diabetischen Nephropathie. Nephro-News 2:4-5; 2001

Originalarbeiten 2000

Harendza S, Lovett DH, Stahl RAK: The hematopoietic transcription factor PU.1 represses gelatinase A transcription in glomerular mesangial cells. J Biol Chem 275:19552-19559; 2000

Wenzel UO, Wolf G, Thaiss F, Helmchen U, Stahl RAK: Renovascular hypertension does not influence repair of the anti-Thy 1 glomerulonephritis in rats. Kidney Int 58:1135-1147; 2000

Wenzel UO: Chemokine bei Nierenerkrankungen. Nieren- und Hochdruckkrankheiten 29:191-196; 2000

Kalluri R, Torre A, Schield CF, Zamborsky ED, Werner MC, Suchin E, Wolf G, Helmchen UH, van den Heuvel LP, Grossmann R, Aradhye S, Neilson EG: Identification of a3, a4 and a5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantations 69:679-683; 2000

Krenz I, Wolf G, Stahl RAK: Premature closure or don´t get lost in your diagnostic workup and blame it on the patient. Nephrol Dial Transplant 15:1072-1075; 2000

von Schrenk T, Ahrens M, de Weerth A, Bobrowski C, Wolf G, Jonas L, Jocks T, Schulz M, Bläker M, Neumaier C, Stahl RAK: CCKB/Gastrin receptors mediate changes in renal sodium and potassium absorption in the isolated perfused rat kidney. Kidney Int 58:995-1003; 2000

Wolf G: Franz Volhard and his pupils tortuous road to renovascular hypertension. Kidney Int 57:2156-2166; 2000

<Wolf G, Wenzel U, Assmann KJM, Stahl RAK: Renal expression of aminopeptidase A in rats with two-kidney, one-clip hypertension. Nephrol Dial Transplant 15:1935-1942; 2000

Wolf G, Porth J, Stahl RAK: Acute renal failure associated with rofecoxis (letter). Annals Internal Med 133:394; 2000

Wolf G: "Show your wound"-medicine and the work of Joseph Beuys. Annals Internal Med 133:927-931; 2000

Hannken T, Schroeder R, Zahner G, Stahl RAK, Wolf G: Reactive oxygen species stimulate p44/42 MAP kinase and induce p27Kip1: role in angiotensin II-mediated hypertrophy of proximal tubular cells. J Am Soc Nephrol 11:1387-1397; 2000

Zöllner B, Speicher A, Janneck M, Stahl RAK, Laufs R: Der besondere Fall: Fieber und Ikterus bei einem 20jährigen Patienten. - Fallbericht - Hamburger Ärzteblatt 12:604-605; 2000

Übersichtsarbeiten 2000

Allolio B, Dambacher M, Dreher R, Felsenberg D, Franke J, Kruse HP, Leidig-Bruckner G, Ringe JD, Semler J, Willvonseder R, Ziegler R: Die Osteoporose des Mannes. Med Klin 95:327-338; 2000

Thaiss F, Stahl RAK: Die IgA-Nephropathie: Klinik, Pathogenese und Therapie der häufigsten Glomerulonephritis. Deutsches Ärzteblatt 41: A2708-A2711; 2000

Shankland SJ, Wolf G: Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation and apoptosis. Am J Physiol 278: F515-F529; 2000

Wolf G: Das Renin-Angiotensin-System und die Progression von chronischen Nierenerkrankungen. Med. Report 19: 2; 2000

Wolf G: Angiotensin II as a mediator of tubulointerstitial injury. Nephrol Dial Transplant 15: (Suppl. 6) 61-63; 2000

von Schrenck T, Wolf G: Das hepatorenale Syndrom: Pathophysiologie, Diagnostik und Therapie. Deutsches Ärzteblatt 43:2858-2862; 2000

Wolf G, Panzer U, Stahl RAK: Peptides and their antagonists in nephropathies. Curr Opin Nephrol Hypertens 9: 233-239; 2000

Wolf G: Free radical production and angiotensin: Curr Hyperten Report
2:165-173; 2000

Wolf G: Cell cycle regulation in diabetic nephropathy. Kidney Int 58:
(Suppl. 77) 53-58; 2000

Wolf G: Angiotensin II as a progression factor for chronic renal disease. Invited contribution, 1st Congress of Nephrology in Internet, 15.2-15.3.2000, www.uninet.edu/cin2000/

Wolf G: Das Renin-Angiotensin-System und die Progression von chronischen Nierenerkrankungen. Dialyse aktuell 4:12-14; 2000

Originalarbeiten 1999

Schneider A, Harendza S, Zahner G, Jocks T, Wenzel U, Wolf G, Thaiss F, Helmchen U, Stahl RAK: Cyclooxygenase metabolites mediate glomerular MCP-1 formation and monocyte recruitment in experimental glomerulonephritis. Kidney Int 55:430-441; 1999

Wolf G, Ziyadeh FN, Stahl RAK: Angiotensin II stimulates expression of transforming growth factor ß receptor type II in cultured mouse proximal tubular cells. J Mol Med 77:556-564, 1999

Wolf G, Kalluri R, Ziyadeh FN, Neilson EG, Stahl RAK: Angiotensin II induces a3(IV) collagen expression in cultured murine proximal tubular cells. Proc Assoc American Physicans 111 (4): 357-364; 1999

Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN, Stahl RAK: Leptin stimulates proliferation and TGF-ß expression in renal glomerular endothelial cells: Potential role in glomerulosclerosis. Kidney Int 56:860-872; 1999

Harendza S, Schneider A, Helmchen U, Stahl RAK: Extracellular matrix deposition and cell proliferation in a model of chronic glomerulonehritis in the rat. Nephrol Dial Transplant 14:2873-2879; 1999

Schneider A, Panzer U, Zahner G, Wenzel U, Wolf G, Thaiss F, Helmchen U, Stahl RAK: Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-ß. Kidney Int 56:135-144; 1999

Panzer U, Schneider A, Wilken J, Thompson DA,Kent SBH, Stahl RAK: The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis. Kidney Int 56:2107-2115; 1999

Wenzel U, Thaiss F, Panzer U, Schwietzer G, Helmchen U, Stahl RAK: Effect of renovascular hypertension on experimental glomerulonephritis in rats. J Lab Clin Med 134:292-303; 1999

Kruse HP: Bone volume, trabecular microarchitecture, degree of mineralization, and fracture risk in osteoporosis. Osteologie 8:135-138; 1999

Wolf G: Endure! how Paul Klee´s illness influenced his art. Lancet 353:1516-1518; 1999

Wolf G, Hegewisch-Becker, Hossfeld DK, Stahl RAK: Hyperuricemia and renal insufficiency associated with malignant disease: urate oxidase as an efficient therapy? Am J Kidney Dis 34:E20-E27; 1999

Wolf G, Wenzel U, Ziyadeh FN, Stahl RAK: ACE inhibitor treatment reduces glomerular p16INK4 and p27Kip1 expression in diabetic BBdp rats. Diabetologia 42:1425-1432; 1999

Übersichtsarbeiten 1999

Wenzel U, Stahl RAK: Chemokines, renal disease, and HIV infection. Nephron 81:5-16; 1999

Panzer U, Stahl RAK: Chemokines and renal inflammation. Néphrologie 20:335-341; 1999

Wolf G: Angiotensin II: a pivotal factor in the progression of renal diseases. Nephrol Dial Transplant 14 (Suppl.1): 42-44; 1999

Wolf G, Ziyadeh FN: Perspectives in basic science: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56:393-405; 1999

Wolf G: Vasoactive factors and tubulointerstitial injury. Kidney Blood Press Res 22:58-66; 1999

Wolf G: Angiotensin II und Progression von Nierenerkrankungen. Mitteil Arbeitsg Klin Nephrol 28:39-40; 1999

Wolf G: AT1 AT2 receptors and angiotensin II-mediated progression of chronic renal disease. ACE inhibitors and/or receptor antagonists for therapeutic intervention ? Kidney Blood Press Res 22:314-315; 1999

Wolf G: Molecular mechanisms of renal hypertrophy: role of p27Kip1. Kidney Int 56:1262-1265; 1999

Wenzel U: Chemokines and renal diseases. Kidney and Blood Press Res 22:405-407; 1999

Wenzel U: Chemokine bei Nierenerkrankungen. Med Report Nr. 22:7; 1999

Originalarbeiten 1998

Frieling I, Kruse HP, Wittig A, Beyer W, Delling G. Phosphatmangel als seltene Ursache einer Osteomalazie - Fallbericht einer mehrjährigen enteralen Sondenernährung und Antazidatherapie: Dtsch med Wschr 123:896-900, 1998

Haberstroh U, Stilo K, Pocock J, Wolf G, Helmchen U, Wenzel U, Zahner G, Stahl RAK, Thaiss F: Nitric oxide suppresses lipopolysaccharide induced mRNA expression of RANTES in renal tissue. J Am Soc Nephrol 9:203-210, 1998

Hannken T, Schroeder R, Stahl RAK, Wolf G: Angiotensin II mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. Kidney Int 54:1923-1933, 1998

Jocks T, Freudenberg J, Zahner G, Stahl RAK: Platelet-activating factor mediates monocyte chemoattractant protein-1 expression in glomerular immune injury. Nephrol Dial Transplant 13:37-43, 1998

Wenzel U, Stahl RAK, Grieshaber M, Schwietzer G: Diagnostisches und therapeutisches Vorgehen der Ärzte bei Patienten mit hypertensiver Krise. Eine Umfrage an 56 Internistischen Kliniken. Dtsch Med. Wschr 123:443-447, 1998

Wolf G, Pfalzer B, Helmchen U, Stahl RAK: Enlarged cervical lymph nodes two years after diagnosis of membranous glomerulonephritis. Nephrol Dial Transplant 13:2679-2681, 1998

Wolf G, Schneider A, Helmchen U, Stahl RAK: AT1-receptor antagonist abolish glomerular MCP-1 expression in a model of mesangioproliferative glomerulonephritis. Exp Nephrol 6:112-120, 1998

Wolf G, Schneider A, Wenzel U, Helmchen U, Stahl RAK: Regulation of glomerular TGF-ß expression in the contralateral kidney of two kidney, one-clip hypertensive rats. J Am Soc Nephrol 9:763-772, 1998

Wolf G, Schröder R, Thaiss F, Ziyadeh FN, Helmchen U, Stahl RAK: Glomerular expression of p27Kip1 in diabetic db/db mouse: role of hyperglycemia. Kidney Int 53:869-879, 1998

Wolf G, Schroeder R, Thaiss F, Ziyadeh FN, Helmchen U, Stahl RAK: Glomerular expression of p27Kip1 in diabetic db/db mouse: role of hyperglycemia. Kidney Int 53: 869-879, 1998

Wolf G: Buchrezension-Wolff/Weihrauch: Internistische Therapie 98/99. Hamburger Ärzteblatt 9:380-381, 1998

Übersichtsarbeiten 1998

Kruse HP: Metabolische Osteopathien. In: Innere Medizin, Bd.I, 9. Auflg, Hrsg Schettler G, Greten H. 623-634, Thieme, Stuttgart-New York 1998

Kruse HP: Knochen. In: Innere Medizin, Bd II, 9. Auflg, Hrsg Schettler G, Greten H. 1270-1277, Thieme, Stuttgart-New York 1998

Kruse HP: Halbiertes Frakturrisiko durch 10% Knochenzuwachs- eine Illusion in der Osteoporosetherapie ? Dtsch med Wschr 123:472-477, 1998

Kruse HP: Bisphosphonate. In: Möglichkeiten, Grenzen und Alternativen der Östrogen-/Gestagen-Substitution nach der Menopause, Hrsg Interdisziplinäres Forum Osteoporose, 74-81. Urban u.Vogel, München 1998

Scheidat S, Stahl RAK: Klinische Differentialdiagnose der Glomerulonephritiden. Hamburger
Ärzteblatt 52:456-462, 1998

Stahl RAK: Non-steroidal anti-inflammatory agents in patients with a renal transplant. Nephrol Dial Transplant 13:1119-1121, 1998

Stahl RAK: Cyclooxygenase-2 (COX-2) and the kidney: current status and potential perspectives. Nephrol Dial Transplant 13:10-12, 1998

Stahl RAK: Chemokines and Nephritis. Clin Exp Nephrol 2:264-270, 1998

Wolf G: The link between angiotensin II and TGG-ß in the kidney. Mineral Elect Metab 24:174-180, 1998

Wolf G, Neilson EG: Morphogenic cues that modulate podocyte growth (Editorial). Kidney Int 53:1087-1088, 1998

Wolf G: Molecular mechanismus of angiotensin II in the kidney: emerging role in the progression of renal disease beyond hemodynamics. Nephrol Dial Transpl 13:1131-1142, 1998

Wolf G: Das akute Nierenversagen: Neue Aspekte zur Pathogenese und Therapie. Med Welt 49:311-317, 1998

Wolf G: Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms. Néphrologie 19:451-456, 1998

Originalarbeiten 1997

Frieling I, Kruse HP: Die Osteoporose des Mannes: Ursachen und Risikofaktoren. Osteologie 5 1996; 204-209

Harendza S, Behrens U, Zahner G, Schneider A, Stahl RAK: In vitro characterization of the mesangial phenotype in a proliferative glomerulonephritis of the rat. Nephrol Dial Transplant 1997; 12:2537-2541.

Mertens PR, Harendza S, Pollock AS, Lovett DH: Glomerular mesangial cell-specific transactivation of MMP-2 transcription is mediated by YB-1. J Biol Chem 1997; 272:22905-22912

Wenzel U, Schneider A, Valente AJ, Abboud HE, Thaiss F, Helmchen U, Stahl RAK: Monocyte chemoattractant protein 1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 1997; 51:770-776

Wolf G, Assmann KJM, Stahl RAK: Overexpression of angiotensinase A abolishs the growth promoting effects of angiotensin II in cultured mouse mesangial cells. Kidney Int 1997; 52:1250-1260

Wolf G, Schroeder R, Ziyadeh FN, Thaiss F, Zahner G, Stahl RAK: High-glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells: relationship to cellular hypertrophy. Am J Physiol 1997; 273:F348-356

Wolf G, Ziyadeh FN, Schroeder R, Stahl RAK: Angiotensin II inhibits inducible nitric oxide synthase in tubular MCT cells by a post-transcriptional mechanism. J Am Soc Nephrol 1997; 8:551-557

Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wenzel U, Zahner G, Stahl RAK: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. J Clin Invest 1997; 100:1047-1058

Zahner G, Harendza S, Müller E, Wolf G, Thaiss F, Stahl RAK: Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. Kidney Int 1997; 51:1116-1123

Übersichtsarbeiten 1997

Stahl RAK: Potential role of chemokines in human renal disease. Am J Kidney Dis 1997; 30:49-52

Wolf G, Ziyadeh FN: The role of angiotensin II in diabetic nephropathy: emphasis on non-hemodynamic mechanisms. Am J Kidney Dis 1997; 29:153-163

Wolf G, Mentzel S, Assmann KJM: Aminopeptidase A: a key enzyme in the intrarenal degradation of angiotensin II. Exp Nephrol 1997; 5:364-369

Wolf G, Ziyadeh FN: Renal hypertrophy induced by angiotensin II. Sem Nephrol 1997; 17:448-454

Originalarbeiten 1996

Jocks T, Zahner G, Freudenberg J, Wolf G, Thaiss F, Helmchen U, Stahl RAK. Prostaglandin E 1 reduces the glomerular mRNA expression of monocyte-chemoattractant protein 1 in anti-thymocyte antibody induced glomerular injury. J Am Soc Nephrol 1996; 7:897-905

Jocks T, Zahner G, Helmchen U, Kneissler U, Stahl RAK. Antibody and complement reduce renal hemodynamic function in the isolated perfused rat kidney. Am J Physiol 1996; 39:F179-F185

Schneider A, Thaiss F, Rau HP, Wolf G, Zahner G, Jocks T, Helmchen U, Stahl RAK. Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis. Possible role of TGFß. Kidney Int 1996; 50:190-199

Singal PC, Pan CQ, Sagar S, Valderrama E, Stahl RAK. Morphine modulates mesangial immunoglobulin G uptake in rats with antithymocyte serum-induced mesangial cell injury. Nephron 1996; 74:197-203

Thaiss F, Haas C, Helmchen U, Wenzel U, Stahl RAK. Angiotensin converting enzyme inhibition in experimental in situ immune complex glomerulonephritis: influence on renal function, proteinuria, and morphology. Nephrol Dial Transplant 1996; 11:40-46

Thaiss F, Wolf G, Assad N, Zahner G, Stahl RAK. Angiotensinase A gene expression and enzyme activity in isolated glomeruli of diabetic rats. Diabetologiy 1996; 39:275-280

Wolf G, Helmchen U, Stahl RAK. Isoproterenol stimulates tubular DNA-replication in mice. Nephrol Dial Transplant 1996; 11:2288-2292

Wolf G, Stahl RAK. Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1. Kidney Int 1996; 50:2112-2119

Wolf G, Wolf W, de Weerth A, Kreymann G. Bedrohliche Blutung bei spontanem Hämatopneumothorax. Intensivmedizin 1996; 33:270-274

Wolf G, Zahner G, Schroeder R, Stahl RAK. Transforming growth factor beta mediates the angiotensin II induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells. Nephrol Dial Transplant 1996; 11:263-269

Wolf G, Zahner G, Ziyadeh FN, Stahl RAK. Concise Report: Cyclosporine A induces transcription of transforming growth factor beta in a cultured murine tubular cell line. Exp Nephrol 1996; 4:304-308

Wolf G, Ziyadeh FN, Zahner G, Stahl RAK. Angiotensin II is mitogenic for cultured rat glomerular endothelial cells. Hypertension 1996; 27:897-905

Übersichtsarbeiten 1996

Frieling I, Kruse HP. Primäre und sekundäre Osteoporose beim Mann, Osteologie 5 (1996) Heft 4, pp

Thaiss F, Stahl RAK. Die Niere bei Diabetes mellitus. Neue Aspekte zur Pathogenese, Diagnostik und Therapie. Z ärztl Fortbild 1996; 90:199-204

Thaiss F, Stahl RAK. Neue Aspekte zur Therapie der Immunkomplexvermittelten rasch progredienten Glomerulonephritis? Med Welt 1996; 47:149-155

Wolf G, Stahl RAK. Angiotensin-II-Wirkungen an der Niere: mehr als ein Vasokonstriktor. Dt Ärztebl 1996; 93:2039-2042

Seitenanfang

Seite drucken

Hauptnavigation:

Publikationen